BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

764 related articles for article (PubMed ID: 18500244)

  • 1. Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response.
    Dewhirst MW; Cao Y; Moeller B
    Nat Rev Cancer; 2008 Jun; 8(6):425-37. PubMed ID: 18500244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hypoxia and angiogenesis].
    Simon JM
    Bull Cancer; 2007 Jul; 94 Spec No():S160-5. PubMed ID: 17846000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the hypoxia-inducible factor in tumor metabolism growth and invasion.
    Brahimi-Horn C; Pouysségur J
    Bull Cancer; 2006 Aug; 93(8):E73-80. PubMed ID: 16935775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia, HIF1 and glucose metabolism in the solid tumour.
    Denko NC
    Nat Rev Cancer; 2008 Sep; 8(9):705-13. PubMed ID: 19143055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting tumour angiogenesis with small molecule inhibitors of hypoxia inducible factor.
    Nordgren IK; Tavassoli A
    Chem Soc Rev; 2011 Aug; 40(8):4307-17. PubMed ID: 21483947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia--a key regulatory factor in tumour growth.
    Harris AL
    Nat Rev Cancer; 2002 Jan; 2(1):38-47. PubMed ID: 11902584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia inducible factor-1 independent pathways in tumor angiogenesis.
    Mizukami Y; Kohgo Y; Chung DC
    Clin Cancer Res; 2007 Oct; 13(19):5670-4. PubMed ID: 17908955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microenvironmental and cellular consequences of altered blood flow in tumours.
    Raghunand N; Gatenby RA; Gillies RJ
    Br J Radiol; 2003; 76 Spec No 1():S11-22. PubMed ID: 15456710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis.
    Carmeliet P; Dor Y; Herbert JM; Fukumura D; Brusselmans K; Dewerchin M; Neeman M; Bono F; Abramovitch R; Maxwell P; Koch CJ; Ratcliffe P; Moons L; Jain RK; Collen D; Keshert E
    Nature; 1998 Jul; 394(6692):485-90. PubMed ID: 9697772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia and cancer.
    Brahimi-Horn MC; Chiche J; Pouysségur J
    J Mol Med (Berl); 2007 Dec; 85(12):1301-7. PubMed ID: 18026916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies.
    Shannon AM; Bouchier-Hayes DJ; Condron CM; Toomey D
    Cancer Treat Rev; 2003 Aug; 29(4):297-307. PubMed ID: 12927570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Angiogenesis and metastasis of carcinoma].
    Chen L; Shibasaki F
    Clin Calcium; 2006 Apr; 16(4):613- 19. PubMed ID: 16582512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermittent hypoxia furthers the rationale for hypoxia-inducible factor-1 targeting.
    Dewhirst MW
    Cancer Res; 2007 Feb; 67(3):854-5. PubMed ID: 17283112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratumoral hypoxia, radiation resistance, and HIF-1.
    Semenza GL
    Cancer Cell; 2004 May; 5(5):405-6. PubMed ID: 15144945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia: a key regulator of angiogenesis in cancer.
    Liao D; Johnson RS
    Cancer Metastasis Rev; 2007 Jun; 26(2):281-90. PubMed ID: 17603752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-induced angiogenesis and vascular endothelial growth factor secretion in human melanoma.
    Rofstad EK; Danielsen T
    Br J Cancer; 1998 Mar; 77(6):897-902. PubMed ID: 9528831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular and molecular mechanisms of inflammation-induced angiogenesis.
    Szade A; Grochot-Przeczek A; Florczyk U; Jozkowicz A; Dulak J
    IUBMB Life; 2015 Mar; 67(3):145-59. PubMed ID: 25899846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypoxia and tumors: does HIF-1 transcription factor favor tumor growth or hypoxia?].
    Vandenbunder B
    Bull Cancer; 1998 Oct; 85(10):843-5. PubMed ID: 9835861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide delivery to cancer: why and how?
    Sonveaux P; Jordan BF; Gallez B; Feron O
    Eur J Cancer; 2009 May; 45(8):1352-69. PubMed ID: 19153039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular basis of the hypoxia response pathway: tumour hypoxia as a therapy target.
    Blancher C; Harris AL
    Cancer Metastasis Rev; 1998 Jun; 17(2):187-94. PubMed ID: 9770115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.